bluebird bio BLUE is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37.
Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Performance in Previous Earnings
The company's EPS missed by $0.04 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at bluebird bio's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.44 | -0.66 | -0.67 |
| EPS Actual | -0.42 | -0.66 | ||
| Price Change % | 1.0% | -5.0% | 14.000000000000002% | -8.0% |
bluebird bio Share Price Analysis
Shares of bluebird bio were trading at $0.3906 as of November 12. Over the last 52-week period, shares are down 86.25%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for bluebird bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
